Increased change by both ECS- and SSRI-treatment (660 probes) | |||
---|---|---|---|
GO number | GO term | No. | P value |
GO:0008203 | cholesterol metabolic process | 16 | 9.8E-09 |
GO:0016126 | sterol biosynthetic process | 10 | 1.1E-08 |
GO:0008202 | steroid metabolic process | 15 | 3.5E-08 |
GO:0006695 | cholesterol biosynthetic process | 9 | 1.3E-06 |
GO:0006694 | steroid biosynthetic process | 11 | 4.4E-06 |
GO:0007399 | nervous system development | 26 | 2.1E-05 |
GO:0010977 | negative regulation of neuron projection development | 10 | 4.1E-05 |
GO:0061564 | axon development | 5 | 5.3E-05 |
GO:0010976 | positive regulation of neuron projection development | 14 | 7.6E-05 |
GO:0042493 | response to drug | 24 | 1.2E-04 |
GO:0051591 | response to cAMP | 9 | 1.4E-04 |
GO:0009790 | embryo development | 10 | 2.2E-04 |
GO:0006950 | response to stress | 7 | 2.3E-04 |
GO:0001649 | osteoblast differentiation | 12 | 2.4E-04 |
GO:0031668 | cellular response to extracellular stimulus | 6 | 2.8E-04 |
GO:0034097 | response to cytokine | 10 | 3.5E-04 |
GO:0007568 | aging | 15 | 3.6E-04 |
GO:0030154 | cell differentiation | 38 | 3.8E-04 |
GO:0009968 | negative regulation of signal transduction | 8 | 4.4E-04 |
GO:0007155 | cell adhesion | 27 | 4.9E-04 |
GO:0006629 | lipid metabolic process | 26 | 5.1E-04 |
GO:0007565 | female pregnancy | 10 | 5.4E-04 |
GO:0043065 | positive regulation of apoptotic process | 21 | 6.1E-04 |
GO:0043627 | response to estrogen | 9 | 7.6E-04 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 9 | 8.3E-04 |
GO:0043407 | negative regulation of MAP kinase activity | 7 | 8.4E-04 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 7 | 9.5E-04 |
GO:0010628 | positive regulation of gene expression | 23 | 9.6E-04 |